FDA Approves New Drug Against Cholesterol

Share On Social!

The U.S. Food and Drug administration (FDA) recently approved a new drug against cholesterol, a condition that affects millions of Latinos, Univision News reports.

Praulent (inhibitor PCSK9), is part of a new generation of drugs that according to doctors has the potential to reduce the number of heart attacks and strokes in patients who suffer from high cholesterol.

In trials PCSK9, “reduced up to 60 percent of bad cholesterol,” even in patients taking statins, the standard prescription drug.

Praulent, has so far been released only to a small pool of patients who suffered a heart attack, serious cardiovascular illnesses or who have hereditary high cholesterol.